Justin J. Boutilier

Justin J. Boutilier

Auto-generated profile, based on publicly available information

Justin J. Boutilier

Telfer School of Management, University of Ottawa, Ottawa, Ontario K1N 9B9, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Operations Research
Verified
Journal Article
Closed access
JBJustin J. Boutilier
Justin J. Boutilier
TCTimothy C. Y. Chan
Timothy C. Y. Chan
Improving Ambulance Response Times in Developing Urban Centers

1 September 2022 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
JBJustin J. Boutilier
Justin J. Boutilier
TCTimothy C. Y. Chan
Timothy C. Y. Chan
Problem definition: Our objective is to design a defibrillator-enabled drone network that augments the existing emergency medical services (EMS) system to rapidly respond to out-of-hospital cardiac arrest (OHCA). Academic/practical relevance: OHCA claims more than 400,000 lives each year in North America and is one of the most time-sensitive medical emergencies. Drone-delivered automated external defibrillators (AEDs) have the potential to be a transformative innovation in the provision of emergency care for OHCA. Methodology: We develop an integrated location-queuing model that incorporates existing EMS response times and is based on the p-median architecture, where each base constitutes an explicit [ ] queue (i.e., Erlang loss). We then develop a reformulation technique that exploits the existing EMS response times, allowing us to solve real-world instances to optimality using an off-the-shelf solver. We evaluate our solutions using a tactical simulation model that accounts for the effects of congestion and dispatching, and we use a machine-learning model to translate our response-time reductions into survival estimates. Results: Using real data from an area covering 26,000 square kilometers around Toronto, Canada, we find that a modest number of drones are required to significantly reduce response times in all regions. An objective function that minimizes average response time results in drone resources concentrated in cities, with little impact on the tail of the distribution. In contrast, optimizing for the tail of the response-time distribution produces larger and more geographically dispersed drone networks that improve response-time equity across the regions. We estimate that the response-time reductions achieved by the drone network are associated with between a 42% and 76% higher survival rate and up to 144 additional lives saved each year across the geographical region we consider. Managerial implications: Overall, this paper provides a realistic framework that can be leveraged by system designers and/or EMS personnel seeking to investigate design questions associated with a drone network. An objective function focused on improving the tail of the response-time distribution is well-suited for use in practice because the model provides equitable solutions that reduce the entire response-time distribution and corresponds to the real-world metrics, on which EMS systems are most commonly evaluated.

21 January 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JBJustin J Boutilier
Justin J Boutilier
TCTimothy C Y Chan
Timothy C Y Chan
MRManish Ranjan
Manish Ranjan
SDSarang Deo
Sarang Deo
Background: The impending scale up of noncommunicable disease screening programs in low- and middle-income countries coupled with limited health resources require that such programs be as accurate as possible at identifying patients at high risk. Objective: The aim of this study was to develop machine learning–based risk stratification algorithms for diabetes and hypertension that are tailored for the at-risk population served by community-based screening programs in low-resource settings. Methods: We trained and tested our models by using data from 2278 patients collected by community health workers through door-to-door and camp-based screenings in the urban slums of Hyderabad, India between July 14, 2015 and April 21, 2018. We determined the best models for predicting short-term (2-month) risk of diabetes and hypertension (a model for diabetes and a model for hypertension) and compared these models to previously developed risk scores from the United States and the United Kingdom by using prediction accuracy as characterized by the area under the receiver operating characteristic curve (AUC) and the number of false negatives. Results: We found that models based on random forest had the highest prediction accuracy for both diseases and were able to outperform the US and UK risk scores in terms of AUC by 35.5% for diabetes (improvement of 0.239 from 0.671 to 0.910) and 13.5% for hypertension (improvement of 0.094 from 0.698 to 0.792). For a fixed screening specificity of 0.9, the random forest model was able to reduce the expected number of false negatives by 620 patients per 1000 screenings for diabetes and 220 patients per 1000 screenings for hypertension. This improvement reduces the cost of incorrect risk stratification by US $1.99 (or 35%) per screening for diabetes and US $1.60 (or 21%) per screening for hypertension. Conclusions: In the next decade, health systems in many countries are planning to spend significant resources on noncommunicable disease screening programs and our study demonstrates that machine learning models can be leveraged by these programs to effectively utilize limited resources by improving risk stratification.

1 December 2021 in Resuscitation
Verified
Journal Article
Closed access
CSClara E. Stoesser
Clara E. Stoesser
JBJustin J. Boutilier
Justin J. Boutilier
CSChristopher L.F. Sun
Christopher L.F. Sun
SBSteven C. Brooks
Steven C. Brooks
SCSheldon Cheskes
Sheldon Cheskes
TCTimothy C.Y. Chan
Timothy C.Y. Chan

1 December 2022 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
JBJustin J Boutilier
Justin J Boutilier
EYErez Yoeli
Erez Yoeli
JRJon Rathauser
Jon Rathauser
POPhilip Owiti
Philip Owiti
RSRamnath Subbaraman
Ramnath Subbaraman
JJJónas Oddur Jónasson
Jónas Oddur Jónasson
Introduction Tuberculosis (TB) is a global health emergency and low treatment adherence among patients is a major barrier to ending the TB epidemic. The WHO promotes digital adherence technologies (DATs) as facilitators for improving treatment adherence in resource-limited settings. However, limited research has investigated whether DATs improve outcomes for high-risk patients (ie, those with a high probability of an unsuccessful outcome), leading to concerns that DATs may cause intervention-generated inequality. Methods We conducted secondary analyses of data from a completed individual-level randomised controlled trial in Nairobi, Kenya during 2016–2017, which evaluated the average intervention effect of a novel DAT-based behavioural support programme. We trained a causal forest model to answer three research questions: (1) Was the effect of the intervention heterogeneous across individuals? (2) Was the intervention less effective for high-risk patients? nd (3) Can differentiated care improve programme effectiveness and equity in treatment outcomes? Results We found that individual intervention effects—the percentage point reduction in the likelihood of an unsuccessful treatment outcome—ranged from 4.2 to 12.4, with an average of 8.2. The intervention was beneficial for 76% of patients, and most beneficial for high-risk patients. Differentiated enrolment policies, targeted at high-risk patients, have the potential to (1) increase the average intervention effect of DAT services by up to 28.5% and (2) decrease the population average and standard deviation (across patients) of the probability of an unsuccessful treatment outcome by up to 8.5% and 31.5%, respectively. Conclusion This DAT-based intervention can improve outcomes among high-risk patients, reducing inequity in the likelihood of an unsuccessful treatment outcome. In resource-limited settings where universal provision of the intervention is infeasible, targeting high-risk patients for DAT enrolment is a worthwhile strategy for programmes that involve human support sponsors, enabling them to achieve the highest possible impact for high-risk patients at a substantially improved cost-effectiveness ratio.

1 November 2022 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
JBJustin J. Boutilier
Justin J. Boutilier
JJJónas Oddur Jónasson
Jónas Oddur Jónasson
EYErez Yoeli
Erez Yoeli
Problem definition: Lack of patient adherence to treatment protocols is a main barrier to reducing the global disease burden of tuberculosis (TB). We study the operational design of a treatment adherence support (TAS) platform that requires patients to verify their treatment adherence on a daily basis. Academic/practical relevance: Experimental results on the effectiveness of TAS programs have been mixed; and rigorous research is needed on how to structure these motivational programs, particularly in resource-limited settings. Our analysis establishes that patient engagement can be increased by personal sponsor outreach and that patient behavior data can be used to identify at-risk patients for targeted outreach. Methodology: We partner with a TB TAS provider and use data from a completed randomized controlled trial. We use administrative variation in the timing of peer sponsor outreach to evaluate the impact of personal messages on subsequent patient verification behavior. We then develop a rolling-horizon machine learning (ML) framework to generate dynamic risk predictions for patients enrolled on the platform. Results: We find that, on average, sponsor outreach to patients increases the odds ratio of next-day treatment adherence verification by 35%. Furthermore, patients’ prior verification behavior can be used to accurately predict short-term (treatment adherence verification) and long-term (successful treatment completion) outcomes. These results allow the provider to target and implement behavioral interventions to at-risk patients. Managerial implications: Our results indicate that, compared with a benchmark policy, the TAS platform could reach the same number of at-risk patients with 6%–40% less capacity, or reach 2%–20% more at-risk patients with the same capacity, by using various ML-based prioritization policies that leverage patient engagement data. Personal sponsor outreach to all patients is likely to be very costly, so targeted TAS may substantially improve the cost-effectiveness of TAS programs. History: This paper has been accepted for the Manufacturing & Service Operations Management Special Section on Responsible Research in Operations Management. Funding: The authors are grateful for financial research support from the MIT Sloan Health Systems Initiative. Supplemental Material: The e-companion is available at https://doi.org/10.1287/msom.2021.1046 .